Browse > Article

The Benefit of Individualized Custom Bolus in the Postmastectomy Radiation Therapy : Numerical Analysis with 3-D Treatment Planning  

Cho Jae Ho (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Cho Kwang Hwan (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Keum Kichang (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Han Yongyih (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Kim Yong Bae (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Chu Sung Sil (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Suh Chang Ok (Department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center)
Publication Information
Radiation Oncology Journal / v.21, no.1, 2003 , pp. 82-93 More about this Journal
Abstract
Purpose : To reduce the Irradiation dose to the lungs and heart in the case of chest wail irradiation using an oppositional electron beam, we used an Individualized custom bolus, which was precisely designed to compensate for the differences In chest wall thickness. The benefits were evaluated by comparing the normal tissue complication probablilties (NTCPS) and dose statistics both with and without boluses. Materials and Methods : Boluses were made, and their effects evaluated in ten patients treated using the reverse hockey-stick technique. The electron beam energy was determined so as to administer 80% of the irradiation prescription dose to the deepest lung-chest wall border, which was usually located at the internal mammary lymph node chain. An individualized custom bolus was prepared to compensate for a chest wall thinner than the prescription depth by meticulously measuring the chest wall thickness at 1 emf intervals on the planning CT Images. A second planning CT was obtained overlying the individuailzed custom bolus for each patient's chest wall. 3-D treatment planning was peformed using ADAC-Pinnacle$^{3}$ for all patients with and without bolus. NTCPS based on 'the Lyman-Kutcher' model were analyzed and the mean, maximum, minimum doses, V$_{50}$ and V$_{95}$ for 4he heari and lungs were computed. Results .The average NTCPS in the ipsliateral lung showed a statistically significant reduction (p<0.01), from 80.2${\pm}$3.43% to 47.7${\pm}$4.61%, with the use of the individualized custom boluses. The mean lung irradiation dose to the ipsilateral iung was also significantly reduced by about 430 cGy, Trom 2757 cGy to 2,327 cGy (p<0.01). The V$_{50}$ and V$_{95}$ in the ipsilateral lung markedly decreased from the averages of 54.5 and 17.4% to 45.3 and 11.0%, respectively. The V$_{50}$ and V$_{95}$ In the heart also decreased from the averages of 16.8 and 6.1% to 9.8% and 2.2%, respectively. The NTCP In the contralateral lung and the heart were 0%, even for the cases with no bolus because of the small effective mean radiation volume values of 4.4 and 7.1%, respectively Conclusion : The use of an Individualized custom bolus in the radiotherapy of postrnastectorny chest wall reduced the NTCP of the ipsilateral lung by about 24.5 to 40.5%, which can improve the complication free cure probability of breast cancer patients.
Keywords
Postmastectomy radiotherapy; 3D-treatment planning; Individualized Custom bolus; Radiation pneumonitis; Dose statistics;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Das IJ, Cheng EC, Freedman G, et al. Lung and heart dose volume analysis with CT simulator in radiation treatment of breast cancer. Int J Radiat Oncol Bioi Phys 1998;42:11-19
2 Segawa Y, Takigawa N, Kataoka M, et al. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 1997;39:91-98   DOI   PUBMED   ScienceOn
3 Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the lung: Non-small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg S, eds. Cancer: Principles and practice of oncology. 4th ed. Philadelphia: Lippincott Co. 1993:676-723
4 Martel MK, Haken RKT, Hazuk MB, et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Bioi Phys 1994;28:575-581   DOI   ScienceOn
5 Fletcher GH, McNeese MD, Oswald MJ. Long-range results for breast cancer patients treated by radical mastectomy and post-operative radiation without adjuvant chemotherapy: an update. Int J Radiat Oncol Biol Phys 1989;17:11-14   PUBMED
6 Cuzick J, Stewart H, Rutqvist L, et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 1994;12:447-453   PUBMED
7 Almond P, Bagne F, Ovadia J, et al. Practical aspects of electron beam treatment planning. Symposium Monograph Presented at the 16th Annual Meeting of the American Association of Physicists in Medicine, Cincinati, Ohio, July 31, 1977
8 Dale E, Olsen DR. Specification of the dose to organs at risk in extemal beam radiotherapy. Acta Oncol 1997;36:129-135   DOI   ScienceOn
9 Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Bioi Phys 1989;16:1623-1630   DOI   ScienceOn
10 Withers HR, Taylor JMG, Macjejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988; 59:751-759
11 Hardman PDJ, Tweeddale PM, Kerr GR, Anderson ED, et al. The effect of pulmonary function of local and locoregional irradiation for breast cancer. Radiother Oncol 1994; 30:33-42   DOI   ScienceOn
12 Archambeau JO, Forell B, Doria R, et al. Use of variable thickness bolus to control election beam penetration in chest wall irradiation. Int J Radiat Oncol Biol Phys 1981; 7:835-842   DOI   PUBMED   ScienceOn
13 Nirnierko A, Goiten M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys 1993;25:51-63
14 Oetzel D, Schraube P, Hensely F, et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995;33:455-460   DOI   PUBMED   ScienceOn
15 Gyenes G, Gagliardi G, Lax I, et al. Reevaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 1997;15:1348-1453   PUBMED
16 Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337(14):949-955   DOI   PUBMED   ScienceOn
17 Kwa SLS, Lebesque JS, Theuws JCM, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 1998;42:1-9
18 Paszat LF, Mackillop WJ, Groome PA, et al. Mortality form myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance. epidemiology. and endresults cancer resgistries. J Clin Oncol 1998;16:2625-2631
19 Pezner RD, Lipsett JA, Forell B, et al. The reverse hockey stick technique: Post-mastectomy radiation therapy for breast cancer patients with locally advanced tumor presentation or extensive loco-regional recurrence. Int J Radiat Oncol Biol Phys 1989;17:191-197   PUBMED
20 Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Eng J Med 1997;337(14):956-962   DOI   ScienceOn
21 Prato F, Kurdyak R, Saibil E, et al. Physiological and radiographic assessment during the development of pulmonary radiation fibrosis. Radiology 1977;122:389-397   PUBMED
22 Schulteiss TE, Orton CG, Peck RA. Models in radiotherapy: volume effects. Med Phys 1983;10:410-415   DOI   ScienceOn
23 Lyman JT. Complication probability as assessed from dosevolume histograms. Radiat res 1985;104:s13-s19   DOI
24 Rothwell RI, Kelly SA, Joslin CAF. Radiation pneumonitis in patients treated for breast cancer. Radiother Oncol 1985;4: 9-14   DOI   ScienceOn
25 Rutqvist L, Lax I, Fornander T, et al. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887-896   DOI   PUBMED   ScienceOn
26 Kelly C, Reid A, Mohan R, et al. Electron beam treatment planning utilizing CCT data. SCientific exhitit presented at the 21st Annual Meeting of the American Society of Therapeutic Radiologists, New Orleans, Louisiana, October 23-27, 1979
27 Kwa SLS, Theuws JCM, Wagenaar A, et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 1998;48;61-69
28 Marks LB, Munley MT, Bentel GC, et al. Physical and biological predictors of changes in whole lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 1997; 39(3):563-570   DOI   PUBMED   ScienceOn
29 Ragazzi G, Cattaneo GM, Fiorino C, et al. Use of dosevolume histograms and biophysical models to compare 2D and 3D irradiation techniques for non-small cell lung cancer. Br J Radiol 1999;72:279-288   PUBMED
30 Price A, Jack WJL, Kerr GR, et al. Acute radiation pneumonitis after postmastectomy irradiation: Effect of fraction size. Clin Oncol 1990;2:224-229   DOI
31 Uematsu M, Bornstein B, Recht A, et al. Long-term results of post-operative radiation therapy following mastectomy with and without chemotherapy in stage I-III breast cancer. Int J Radiat Oncol Biol Phys 1993;25:765-770   DOI   PUBMED   ScienceOn
32 Hurkmans CW, Borger JH, Bas LJ, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 2000;55:145-151   DOI   ScienceOn